Omnes has injected €10.8m into France-based ABMI, an engineering and industrial innovation advisory firm, investing alongside MACSF, Momentum Invest and the company's management.
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
Ergon uses its Ergon Capital Partners IV vehicle, which closed on €580m in March 2019
Buyout of the baking product company is the GP's fifth UK deal since opening a Manchester office
Sale ends an eight-year holding period for the GP, which owned an 83.4% stake in the company